-
Shanghai Cell Therapy Group’s Second Attempt at HK IPO Receives Green Light from CICC and CCB International
•
Shanghai Cell Therapy Group Co., Ltd., a leading player in China’s cellular medical health sector, has announced its second filing for an IPO on the Hong Kong Stock Exchange (HKEX), with joint sponsors being China International Capital Corporation Hong Kong Securities Limited (CICC) and CCB International Financial Limited (CCB International)…
-
Shanghai Cell Therapy Group Partners with Nantong Federation for Comprehensive Health Services Platform
•
Shanghai Cell Therapy Group has entered into a partnership with the Nantong Federation of Industry and Commerce, aiming to leverage their respective advantageous resources to create a comprehensive medical service platform. The collaboration will provide a range of health services, including high-end medical care, cell health, early tumor screening, and…
